AB Science

AB Science is a France-based pharmaceutical company founded in 2001 by a team of researchers, clinicians, and entrepreneurs. It specializes in the research, discovery, development, and marketing of protein kinase inhibitors, focusing on targeted therapies using tyrosine kinase inhibitors. The company aims to address significant unmet medical needs in various fields, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases. AB Science is committed to innovating and developing new drugs that can significantly improve the lives of patients and enhance treatment outcomes in both human and veterinary medicine.